These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 33427493)

  • 1.
    He S; Liu Y; Li Q; Lyu W; Feng F; Guo Q; Zhao L; Sun H
    Future Med Chem; 2021 Feb; 13(4):341-361. PubMed ID: 33427493
    [No Abstract]   [Full Text] [Related]  

  • 2. Discovery of human autophagy initiation kinase ULK1 inhibitors by multi-directional
    Mu P; Karuppasamy R
    J Recept Signal Transduct Res; 2019 Apr; 39(2):122-133. PubMed ID: 31311432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of novel PI3Kδ inhibitors by docking, ADMET prediction and molecular dynamics simulations.
    Liu YY; Feng XY; Jia WQ; Jing Z; Xu WR; Cheng XC
    Comput Biol Chem; 2019 Feb; 78():190-204. PubMed ID: 30557817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of 5-bromo-4-phenoxy-N-phenylpyrimidin-2-amine derivatives as novel ULK1 inhibitors that block autophagy and induce apoptosis in non-small cell lung cancer.
    Sun D; Yang Z; Zhen Y; Yang Y; Chen Y; Yuan Y; Zhang L; Zeng X; Chen L
    Eur J Med Chem; 2020 Dec; 208():112782. PubMed ID: 32961380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conservation of structure, function and inhibitor binding in UNC-51-like kinase 1 and 2 (ULK1/2).
    Chaikuad A; Koschade SE; Stolz A; Zivkovic K; Pohl C; Shaid S; Ren H; Lambert LJ; Cosford NDP; Brandts CH; Knapp S
    Biochem J; 2019 Mar; 476(5):875-887. PubMed ID: 30782972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-Based Virtual Screening towards the Discovery of Novel ULK1 Inhibitors with Anti-HCC Activities.
    Gao Y; Zhou Z; Zhang T; Xue S; Li K; Jiang J
    Molecules; 2022 Apr; 27(9):. PubMed ID: 35565977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of Novel Src Inhibitors: Pharmacophore-Based Virtual Screening, Molecular Docking and Molecular Dynamics Simulations.
    Zhang Y; Zhang TJ; Tu S; Zhang ZH; Meng FH
    Molecules; 2020 Sep; 25(18):. PubMed ID: 32911607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacophore modeling, multiple docking, and molecular dynamics studies on Wee1 kinase inhibitors.
    Hu Y; Zhou L; Zhu X; Dai D; Bao Y; Qiu Y
    J Biomol Struct Dyn; 2019 Jul; 37(10):2703-2715. PubMed ID: 30052133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NPM1 mutant maintains ULK1 protein stability via TRAF6-dependent ubiquitination to promote autophagic cell survival in leukemia.
    Tang Y; Tao Y; Wang L; Yang L; Jing Y; Jiang X; Lei L; Yang Z; Wang X; Peng M; Xiao Q; Ren J; Zhang L
    FASEB J; 2021 Feb; 35(2):e21192. PubMed ID: 33201521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ULK1 inhibition as a targeted therapeutic strategy for FLT3-ITD-mutated acute myeloid leukemia.
    Hwang DY; Eom JI; Jang JE; Jeung HK; Chung H; Kim JS; Cheong JW; Min YH
    J Exp Clin Cancer Res; 2020 May; 39(1):85. PubMed ID: 32393312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-Based Virtual Screening of Tumor Necrosis Factor-α Inhibitors by Cheminformatics Approaches and Bio-Molecular Simulation.
    Halim SA; Sikandari AG; Khan A; Wadood A; Fatmi MQ; Csuk R; Al-Harrasi A
    Biomolecules; 2021 Feb; 11(2):. PubMed ID: 33671607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Small Molecule Inhibition of the Autophagy Kinase ULK1 and Identification of ULK1 Substrates.
    Egan DF; Chun MG; Vamos M; Zou H; Rong J; Miller CJ; Lou HJ; Raveendra-Panickar D; Yang CC; Sheffler DJ; Teriete P; Asara JM; Turk BE; Cosford ND; Shaw RJ
    Mol Cell; 2015 Jul; 59(2):285-97. PubMed ID: 26118643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of novel CK2 leads by cross-docking based virtual screening.
    Sun H; Wu X; Xu X; Jiang Z; Liu Z; You Q
    Med Chem; 2014; 10(6):628-39. PubMed ID: 24286395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery and Design of Novel Small Molecule GSK-3 Inhibitors Targeting the Substrate Binding Site.
    Rippin I; Khazanov N; Shirley Ben Joseph ; Kudinov T; Berent E; Arciniegas Ruiz SM; Marciano D; Levy L; Gruzman A; Senderowitz H; Eldar-Finkelman H
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33218072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Virtual screening of small molecules databases for discovery of novel PARP-1 inhibitors: combination of in silico and in vitro studies.
    Ekhteiari Salmas R; Unlu A; Bektaş M; Yurtsever M; Mestanoglu M; Durdagi S
    J Biomol Struct Dyn; 2017 Jul; 35(9):1899-1915. PubMed ID: 27315035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of new small-molecule cyclin-dependent kinase 6 inhibitors through computational approaches.
    Luo X; Zhao Y; Tang P; Du X; Li F; Wang Q; Li R; He J
    Mol Divers; 2021 Feb; 25(1):367-382. PubMed ID: 32770459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design of novel rho kinase inhibitors using energy based pharmacophore modeling, shape-based screening, in silico virtual screening, and biological evaluation.
    Mishra RK; Alokam R; Singhal SM; Srivathsav G; Sriram D; Kaushik-Basu N; Manvar D; Yogeeswari P
    J Chem Inf Model; 2014 Oct; 54(10):2876-86. PubMed ID: 25254429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of novel CDK 9 inhibitors based on virtual screening, molecular dynamics simulation, and biological evaluation.
    Wu M; Han J; Liu Z; Zhang Y; Huang C; Li J; Li Z
    Life Sci; 2020 Oct; 258():118228. PubMed ID: 32781071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure of the human autophagy initiating kinase ULK1 in complex with potent inhibitors.
    Lazarus MB; Novotny CJ; Shokat KM
    ACS Chem Biol; 2015 Jan; 10(1):257-61. PubMed ID: 25551253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of promising B lymphocyte kinase inhibitors using structure-guided virtual screening.
    Yang S; Wahab S; Almoyad MAA; Chen Y; Kalam N; Khalid M
    J Biomol Struct Dyn; 2024 Aug; 42(13):7054-7064. PubMed ID: 37688373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.